IL-27 Reduces Fat Accumulation in a High-Fat Diet Mouse Model
IL-27 Attenuates Fat Accumulation in a High-Fat Diet Mouse Model Leveraging NMR technology
Overview:
In this webinar, Katie will review how optical imaging works and provide some common examples of how it’s used within preclinical research. She will then introduce the Newton 7.0 FT500, an optical imaging system manufactured by Vilber that includes bioluminescence, fluorescence, and 3D tomography capabilities. She will end the webinar by going through some of the most common questions/considerations that come up for those looking to add optical imaging capabilities to their lab.
The Newton 7.0 is a highly sensitive optical imaging system dedicated to preclinical imaging of small animals in vivo, and may also be used on a variety of in vitro and ex vivo samples. It combines the best optics and animal handling features for high-quality image data and quantification. The Newton 7.0 system is capable of bioluminescence, fluorescence as well as 3D tomographic imaging.
The system is:
Whether you are just exploring the idea of adding optical capabilities to your lab or you’ve been imaging for years, you won’t want to miss the opportunity to learn about this cool new technology and ask questions about your specific research applications and study design.
Learning objectives:
In collaboration with The Keenan Research Center for Biomedical Science, Toronto
IL-27 Attenuates Fat Accumulation in a High-Fat Diet Mouse Model Leveraging NMR technology
Research Beyond the PIXImus: Considerations for Replacing a Legacy Small Animal DXA System
View Paper Here Degenerative mitral valve regurgitation is a progressive disease involving the
This study uses longitudinal intravital confocal microscopy in a live PDAC mouse model
This study investigates how intermittent hypoxia drives lung fibrosis using precise oxygen cycling
Publication Highlight: The Synergistic Power of Intermittent Fasting and Threonic Acid in DIO
Enter your details and we’ll email the requested brochure to you.